CCBs can also be useful after myocardial infarction (MI); however, certain criteria including a prior attempt with combinatorial therapy of a beta blocker and an angiotensin-converting enzyme (ACE) inhibitor should be met before proceeding [137]. This evidence concerns the gene ACE and myocardial infarction.